NCT06993454View on ClinicalTrials.gov

Acute Exercise and Endogenous Glucose Production in Type 2 Diabetes: Implications for Glycemic Control and Treatment of Hepatic Steatosis

NARecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 25, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
Type 2 DiabetesHepatic Steatosis
Interventions
OTHER

Magnetic Resonance Liver Assessment

Liver fat will be measured by MR imaging to assess level of hepatic steatosis.

OTHER

Bike Exercise VO2max

Maximal fitness measured by cycle ergometer.

OTHER

DEXA

Measure body composition (fat and lean body mass).

Trial Locations (1)

32804

RECRUITING

AdventHealth Translational Research Institute, Orlando

All Listed Sponsors
lead

AdventHealth Translational Research Institute

OTHER